GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

HTCR · Jun 30, 2026

HeartCore Enterprises, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001493152-26-037604General Corporate
Capex intensity50thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.28% · OPTIONAL · VALID

Revenue growth0thOwn-history percentile · N=10
Evidence method

Yoy · gp.fundamentals.revenue

-93.22% · CORE · VALID

Gross margin0thOwn-history percentile · N=14
Evidence method

Level · gp.fundamentals.gross_margin

-21.84% · CORE · VALID

Operating margin0thOwn-history percentile · N=14
Evidence method

Level · gp.fundamentals.operating_margin

-256.36% · CORE · VALID

SBC intensity7thOwn-history percentile · N=14
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

0.00% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History15 statesHistory building
Period transition

What moved in the state?

Capex Intensity Increased
Previous
0.08%
Current
0.28%
Delta
0.20%
Growth Decreased
Previous
-65.27%
Current
-93.22%
Delta
-27.96%
Margin Decreased
Previous
5.94%
Current
-21.84%
Delta
-27.79%
Profitability Decreased
Previous
-123.65%
Current
-256.36%
Delta
-132.71%
Sbc Intensity Decreased
Previous
0.16%
Current
0.00%
Delta
-0.16%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.